Management of myasthenia gravis

Seminars in Neurology
David S Saperstein, R J Barohn

Abstract

Although once a severe and often fatal illness, myasthenia gravis can now be well managed with several relatively safe and effective therapies. Management involves a graded approach, beginning with cholinesterase inhibitors for mild symptoms and advancing to immunomodulating medications for more severe weakness. There are several immunomodulating agents from which to choose; selection is based largely on time to clinical effect and adverse effects. This review will discuss the selection and use of therapies for patients with myasthenia gravis.

Citations

Jan 19, 2008·Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society·Patricia I Geddie
May 11, 2010·Pediatric Emergency Care·James RookGail M Stewart
Aug 28, 2012·Seminars in Thoracic and Cardiovascular Surgery·Victor Tomulescu, Irinel Popescu
Jun 24, 2009·Optometry : Journal of the American Optometric Association·Marie I Bodack
Jan 1, 2008·Seminars in Thoracic and Cardiovascular Surgery·Shannon L Castle, Kemp H Kernstine
Jul 26, 2008·Journal of Neuroimmunology·Isabel IllaEduard Gallardo
Jun 1, 2007·Autoimmunity Reviews·Mario García-CarrascoRicard Cervera
May 11, 2006·Neurologic Clinics·Jay R Bhatt, Robert M Pascuzzi
Aug 23, 2007·Journal of Cardiovascular Electrophysiology·Anil GehiJonathan Langberg
Jun 24, 2008·Annals of the New York Academy of Sciences·Julie Rowin
Jul 11, 2012·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Suna YapaliFulya Gunsar
Mar 27, 2010·The Annals of Thoracic Surgery·Seth D Goldstein, Stephen C Yang
Jan 20, 2015·Journal of Pediatric Surgery·Seth D GoldsteinPaul Colombani
Sep 23, 2016·Journal of the Neurological Sciences·Lauren Gotterer, Yuebing Li
Jun 8, 2011·British Journal of Hospital Medicine·Kerstie Stephenson, Jonathan Wilkinson
May 28, 2008·Magyar sebészet·Judit HallayBéla Fülesdi
Feb 6, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Federica UbialiFulvio Baggi
Dec 7, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yuefang ZhouHenry J Kaminski
Jun 6, 2018·Journal of Neuromuscular Diseases·Océane Landon-CardinalOlivier Benveniste
Jan 7, 2020·Journal of the Neurological Sciences·John Morren, Yuebing Li

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.